PARP inhibitor synthetic lethality in ATM biallelic mutant cancer cell lines is associated with BRCA1/2 and RAD51 downregulation
Asli Muvaffak(GlaxoSmithKline (United States)), Kevin Coleman(GlaxoSmithKline (United States))
Cited by 8
Related Papers
PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer
|Proceedings of the National Academy of Sciences|2016|825
Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKBβ
|Journal of Clinical Investigation|2003|712
Identification of CDK4 Sequences Involved in Cyclin D1 and p16 Binding
|Journal of Biological Chemistry|1997|99